441 | GOLCADOMIDE, A CEREBLON E3 LIGASE MODULATOR (CELMoD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED PHASE 1/2 RESULTS

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	R. Cordoba, J. Chavez, G. Fleury Perini, L. Nastoupil, J. Mészáros Jørgensen, P. Bories, F. Bijou, P. Luigi Zinzani, J. Munoz, C. Carpio, A. Costa, W. S. Kim, P. Rao, B. de Moucheron, G. Yang, S. Carrancio, A. Sudhindra, M. Pourdehnad, J. Voetsch, J. Michot
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items